Infection Rate and Clinical Symptoms of Trichomoniasis among Women Referring to the Hospital in Mahshahr City in Khuzestan Province, Southwest of Iran

Document Type : Original Research

Authors
A. Dalimi
E. Moradi
J. Sadraei
M. Pirestani
Parasitology Department, Medical Sciences Faculty, Tarbiat Modares University
10.52547/iem.8.1.27
Abstract
Backgrounds: Trichomoniasis is one of the most common sexually transmitted infections in the world. The main aim of the present descriptive study was to determine the prevalence rate and clinical symptoms of trichomoniasis among women referring to the hospital in Mahshahr city in Khuzestan province, southwest of Iran.

Materials & Methods: Urine samples were collected from 2200 women referring to Imam Musa Kazim hospital in Mahshahr city. In addition, 500 Pap smear samples were used for early detection of Trichomonas vaginalis. At first, parasitological tests were performed to detect T. vaginalis in urine and dissolved Pap smear samples using microscopic examination. Finally, DNA extraction was performed on 34 parasites isolated from positive urine and Pap smear samples. Then the 18s rRNA gene of the parasite was amplified by PCR method. The PCR products of the 18s rRNA gene were finally sequenced.

Findings: The prevalence rate of this parasite was determined to be 1.54%. The highest prevalence rate of infection and clinical symptoms were observed in women aged 31-40 years. Totally, clinical symptoms were observed in 64.70% of infected women, including vaginal itching and irritation (64.70%) and abnormal discharge (26.47%).

Conclusion: The prevalence rate of Trichomonas infection was relatively low in women living in Mahshahr. In addition, about 35.29% of infected women were found to be clinically asymptomatic.

Keywords

Subjects

1. Johnson RM. Trichomoniasis. In: Satoskar AR, Simon GL, Hotez PJ, Tsuji M. Medical parasitology, 2009, Landes Bioscience, Austin, Texas USA, PP 222-226.
2. Newman L, Rowley J, Hoorn SV, Wijesooriya NS, Unemo M, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015; 10(12): e0143304.
3. Thomason J L, Gelbart S M, Sobun J F, Schulien M B, Hamilton P R. Comparison of four methods to detect Trichomonas vaginalis. J Clin Microbiol 1988; 26(9): 1869–1870.
4. Rompalo AM, Gaydos CA, Shah N, Tennant M, Crotchfelt KA, Madico G, Quinn TC. et al., Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis 2001, 33(9) : 1455–1461.
5. Beal C, Goldsmith R, Kotby M, Sherif M el-Tagi, A, Farid A, et al. The plastic envelope method, a simplified technique for culture diagnosis of trichomoniasis. J Clin Microbiol 1992; 30(9): 2265–2268.
6. Lisi PJ, Dondero RS, Kwiatkoski D, Spence MR, Rein MF, Alderete JF. Monoclonal-antibody-based enzyme-linked immunosorbent assay for Trichomonas vaginalis. J Clin Microbiol 1988; 26(9):1684-6
7. Bickley LS, Krisher KK, Punsalang Jr A, Trupei MA, Reichman RC, Menegus MA. Comparison of direct fluorescent antibody, acridine orange, wet mount, and culture for detection of Trichomonas vaginalis in women attending a public sexually transmitted diseases clinic. Sex. Transm Dis 1989; 16(3):127-31.
8. Smith, R.F., Detection of Trichomonas vaginalis in vaginal specimens by direct immunofluorescence assay. J Clin. Microbiol 1986; 24(6): 1107–1108.
9. Carney J A, Unadkat P, Yule A, Rajakumar R, Lacey CJ, Ackers JP. New rapid latex agglutination test for diagnosing Trichomonas vaginalis infection. J Clin. Pathol 1988;41(7):806-8.
10. Mayta H, Gilman RH, Calderon MM, Gottlieb A, Soto G, Tuero I, et al. (2000) 18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis. J Clin Microbiol 38, 2683.
11. Alderete JF, O'Brien JL, Arroyo R, Engbring JA, Musatovova O, Lopez O, et al. (1995) Cloning and molecular characterization involved in Trichomonas vaginalis cytoadherence. Mol Microbiol 17, 69.
12. Paces J, Urbankova V, Urbanek P (1992) Cloning and characterization of a repetitive DNA sequence specific for Trichomonas vaginalis. Mol Biochem Parasitol 54, 247.
13. Kengne P1, Veas F, Vidal N, Rey JL, Cuny G (1994) Trichomonas vaginalis repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol 40, 819.
14. Riley DE, Roberts M C, Takayama T, Krieger JN (1992) Development of a polymerase chain reaction based diagnosis of Trichomonas vaginalis. J Clin Microbiol 30, 465.
15. Jordan JA, Lowery D, Trucco M (2001) Taqman-based detection of Trichomonas vaginalis DNA from female genital specimens. J Clin Microbiol 39, 3819.
16. Katiyar, SK, and Edlind, TD (1994) β-Tubulin genes of Trichomonas vaginalis. Mol Biochem Parasitol 64, 33.
17. Madico G, Quinn TC, Rompalo A, McKee KT Jr, Gaydos CA (1998) Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 36, 3205.

18. Harp DF, Chowdhury I. Trichomoniasis: Evaluation to execution. Eur J Obstet Gynecol Reprod Biol 2011; 157: 3-9.
19. Rezaeian M, Vatanshenassan M, Rezaie S, Mohebali M, Niromand N, et al. Prevalence of T. vaginalis using parasitological methods in Tehran. Iran J Parasitol 2009; 4 (4): 43-7.
20. Hezarjaribi HZ, Fakhar M, Shokri A. T. vaginalis infection among Iranian general population of women: a systematic review and meta-analysis. Parasitol Res 2015; 1-10.
21. Hall TA. Bioedit: A user-friendly biological sequence alignment editor and analysis program for windows 95/98/Nt, Nucleic Acids Symposium Series, 1999, pp. 95–98, Oxford University Press, Oxford.
22. Larkin MA, Blackshields G, Brown N, Chenna R, Mcgettigan PA, et al. Clustal W and clustal X version 2.0, Bioinformatics 2007; 23, 2947–2948. doi.org/10.1093/bioinformatics/btm404
23. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. Mega6: Molecular evolutionary genetics analysis version 6.0, Mol Biol Evol. 2013; 30, 2725–2729. doi.org/10.1093/molbev/mst197
24. Kim SR, Kim JH, Gu NY, Kim YS, Hong YC, et al. Prevalence of Trichomoniasis by PCR in women attending health screening in Korea. Korean J Parasitol 2016 Apr; 54 (2): 187-190.
25. Kriesel JD, Bhatia AS, Barrus C, Vaughn M, Gardner J, et al. Multiplex PCR testing for nine different sexually transmitted infections. Int J STD AIDS. 2016; 27(14):1275-1282.
26. Miranda AE, Pinto VM, Gaydos CA. Trichomonas vaginalis infection among young pregnant women in Brazil. Braz J Infect Dis 2014; 372: 1-3.
27. Gregson S, Mason PR, Garnett GP, Zhuwau T, Nyamukapa CA, et al. A rural HIV epidemic in Zimbabwe? Findings from a population-based survey. Int J STD AIDS. 2001;12(3):189–96.
28. Klinger EV, Kapiga SH, Sam NE, Aboud S, Chen CY, et al. A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Sex Transm Dis. 2006; 33(12):712–8.
29. Mgone CS, Lupiwa T, Yeka W. High prevalence of Neisseria gonorrhoeae and multiple sexually transmitted diseases among rural women in the Eastern Highlands Province of Papua New Guinea, detected by polymerase chain reaction. Sex Transm Dis. 2002;29(12):775–9.
30. Wangnapi RA, Soso S, Unger HW, Sawera C, Ome M, et al. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sex Transm Infect. 2015;91(3):194–200.
31. Miller WC, Swygard H, Hobbs MM, Ford CA, Handcock MS, et al. The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis. 2005 32(10):593-8.
32. Spinillo A, Bernuzzi AM, Cevini C, Gulminetti R, Luzi S, et al. The relationship of bacterial vaginosis, Candida and Trichimonas infection to sympthomatic vaginitis in postmenopausal women attending a vaginitis clinic. Mathuritas 1997; 27 (3): 253-60.
33. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, et al. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin Infect Dis. 2007;45(10):1319–26.
34. Bafghi AF, Aflatoonian A, Barzagar K, Ghafourzadeh M. Frequency distribution of trichomoniasis in pregnant women referred to health centers of Ardakan, Meibod and Yazd, Iran. Jundishapur J Microbiol 2009; 2 (4): 132-139.
35. Valadkhani Z, Hassan N, Amirkhani A, Esmaili I, Sabzali T. The Prevalence of Trichomoniasis in High-Risk Behavior Women Attending the Clinics of Tehran Province Penitentiaries. IJMS. 2010; 35 (3): 190-194.
36. Ziaei Hezarjaribi H, Taghavia M, Fakhar M, Gholami S. Direct diagnosis of Trichomonas vaginalis infection on archived Pap smears using Nested PCR. Acta Cytologica 2015; 59: 104–108.
37. Rabbani M, Saberi B, Jafarian Dehkordi AS, Mardanian F. Trichomonas vaginalis infection using PCR. J Shahrekord Univ Med Sci 2003, 5 (1): 4- 9. (Persian)
38. de Jong AS, Rahamat-Langendoen JC, van Alphen P, Hilt N, van Herk C, Pont S, Melchers W, van de Bovenkamp J. Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands. Inter J STD & AIDS, 2016; 27(10):856-860.
39. Pereyre, S, Laurier Nadalié C, Bébéar C Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases. Clin Microbiol Infec. 2017; 23(2): 122. e1-122. e7.
40. Field, N, Clifton S, Alexander S, Ison CA, Khanom R, Saunders P, Hughes G, Heath L, Beddows S, Mercer CH, Tanton C, Johnson AM, Sonnenberg P. Trichomonas vaginalis infection is uncommon in the British general population: implications for clinical testing and public health screening. Sex Transm Infect. 2018; 94(3):226-229.
41. Miranda, AE, Pinto VM, Gaydos CA Trichomonas vaginalis infection among young pregnant women in Brazil. Brazilian J Infect Dis. 2014; 18(6):669-671.
42. Davey JDL, Shull HI, Billings JD, Wang D, Adachi K , et al. Prevalence of Curable Sexually Transmitted Infections in Pregnant Women in Low- and Middle-Income Countries From 2010 to 2015. A Systematic Review. Sex Transm Dis. 2016; 43(7):450-458.
43. Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis 2015; 15:307
44. Freeman AH, Katz KA, Pandori MW, Rauch LM, Kohn RP, et al. Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex Transm Dis. 2010;37(3):165–8.
45. Rathod SD, Krupp K, Klausner JD, Arun A, Reingold AL, et al. Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis. Sex Transm Dis. 2011;38(9):882–6.
46. Schwebke J.R., Burgess D. Trichomoniasis. Clin Microbiol Rev. 2004 Oct. 17(4):794-803,
47. Anderson BL, Cosentino LA, Simhan HN, Hillier SL. Systemic immune response to Trichomonas vaginalis infection during pregnancy. Sex Transm Dis. 2007 Jun. 34(6):392-6.
48. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006 Aug 4. 55:1-94.
Infection Epidemiology and Microbiology
Volume 8, Issue 1
February 2022
Pages 27-34